Breast cancer is a complex disease and there are several molecular alterations associated with its pathogenesis. Although considerable efforts have been made for the development of effective therapy ...
Phase II Trial of Docetaxel, Cisplatin, Fluorouracil, and Leucovorin as Induction for Squamous Cell Carcinoma of the Head and Neck PURPOSE: Stealth (ALZA Corporation, Palo Alto, CA) liposomal drug ...
Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma Patients with SCLC and progression on ...
PharmaGap Inc. reports significant progress in development and initial testing of a liposomal delivery formulation for PharmaGap's lead cancer drug GAP-107B8 for therapeutic use in humans. The ...
CMV-SPORT-β-gal Haloperidol Sigma receptors Haloperidol-conjugated targeted lipoplex showed tenfold higher reporter gene expression in MCF-7 cells in comparison to control lipoplex [123] p53 Estradiol ...